See how top analysts and institutions rate RKT — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| BofA Securities | Upgrade | Neutral → Buy | $24 | 2025-09-10 |
| BTIG Research | Initiated | Buy | $25 | 2025-08-19 |
| Morgan Stanley | Resumed | Equal-Weight | $16 | 2025-08-14 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 0 | 3 | 10 | 0 | 0 |
| October 2025 | 0 | 3 | 10 | 0 | 0 |
| September 2025 | 0 | 3 | 9 | 0 | 1 |
| August 2025 | 0 | 2 | 10 | 0 | 1 |
The majority of institutional investors have issued a "Buy" rating for RKT, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
